Endocrine-related cancer, ‎1351-0088

Journal

Publications

  1. Published
  2. Published

    Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours

    Eamonn Maher & 1 others, , 1 Jun 2009, In: Endocrine-related cancer. 16, 2, p. 515-525 11 p.

    Research output: Contribution to journalArticle

  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. E-pub ahead of print

    In Touch with your Feminine Side: How Oestrogen Metabolism Impacts Prostate Cancer

    Paul Foster, 18 May 2016, (E-pub ahead of print) In: Endocrine-related cancer.

    Research output: Contribution to journalArticlepeer-review

  13. Published

    Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis

    Krishnarajah Nirantharakumar, , G Neil Thomas, & , 29 Apr 2021, In: Endocrine-related cancer. 28, 5, p. 325-335

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. Published
  16. Published

    Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome

    Cristina Ronchi, , , , , , , & , Aug 2015, In: Endocrine-related cancer. 22, 4, p. 531-543 13 p.

    Research output: Contribution to journalArticlepeer-review

  17. E-pub ahead of print

    PRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase A

    Davide Calebiro, , , & , 1 Sep 2020, (E-pub ahead of print) In: Endocrine-related cancer.

    Research output: Contribution to journalArticlepeer-review

  18. Published

    Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)

    Manju Kurian, Neil Morgan, , , , , , , , , , , Paul Gissen & Eamonn Maher, 29 Apr 2008, In: Endocrine-related cancer. 70, 18, p. 1623-9 7 p.

    Research output: Contribution to journalArticle

  19. Published

    Radiation-induced hypopituitarism

    Niki Karavitaki & , Sep 2009, In: Endocrine-related cancer. 16, 3, p. 733-72 40 p.

    Research output: Contribution to journalArticlepeer-review

  20. Published

    STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model

    Paul Foster, , , , , , , & , 2013, In: Endocrine-related cancer. 20, 1, p. 53-64 12 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 Next